[PHAS] QoQ Quarter Result on 31-Mar-2020 [#Q1]

Stock
[PHAS] PhaseBio Pharmaceuticals, Inc.
Announcement Date
12-May-2020
Financial Year
2020
Quarter
31-Mar-2020 [#Q1]
Profit Trend
QoQ- -31.54%
YoY- -104.37%
Quarter Report
PHAS's Result
PHAS's Financial Summary
View:
Show?
Quarter Result
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
Revenue 0 241 703 320 764 241 703 -
PBT -30,375 -25,143 -28,142 -14,905 -11,331 -11,391 -9,232 120.41%
Tax -4,071 -4,289 -3,665 -239 314 465 469 -
NP -30,375 -25,143 -28,142 -14,905 -11,331 -11,391 -9,232 120.41%
Tax Rate - - - - - - - -
Total Cost 30,375 25,384 28,845 15,225 12,095 11,632 9,935 109.93%
Ratio Analysis
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
NP Margin -9,492,187,500,000,000.00 -10,432.78 -4,003.13 -4,657.81 -1,483.12 -4,726.56 -1,313.23 34175661542.98%
Per Share
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
EPS -1.03 -0.86 -0.98 -0.52 -0.39 -0.40 -0.33 112.83%
EPS Diluted -1.03 -0.86 -0.98 -0.52 -0.39 -0.40 -0.33 112.83%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.